Market revenue in 2024 | USD 91.6 million |
Market revenue in 2030 | USD 103.9 million |
Growth rate | 2.1% (CAGR from 2025 to 2030) |
Largest segment | Conventional |
Fastest growing segment | Molecular |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Molecular, Conventional |
Key market players worldwide | BioMerieux SA, Abbott, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG ADR, Becton Dickinson & Co, Qiagen NV, Thermo Fisher Scientific Inc, Meridian Bioscience, Hologic, Inc. |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hospital acquired infections diagnostics market will help companies and investors design strategic landscapes.
Conventional was the largest segment with a revenue share of 54.15% in 2024. Horizon Databook has segmented the Australia hospital acquired infections diagnostics market based on molecular, conventional covering the revenue growth of each sub-segment from 2018 to 2030.
Australia’s HAI diagnostics market is dominated by global players such as Hologic, Siemens, and Roche, alongside regional distributors. The focus on advanced molecular diagnostics for bloodstream infections and pneumonia aligns with Australia’s commitment to high healthcare standards.
The competitive landscape is shaped by the strong presence of private laboratories such as Sonic Healthcare, which play a critical role in offering diagnostic services to hospitals.
The Therapeutic Goods Administration (TGA) regulates diagnostic devices in Australia, ensuring compliance with stringent safety and efficacy standards. The regulatory pathway for molecular diagnostics emphasizes robust clinical evidence, which can extend approval timelines.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia hospital acquired infections diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Australia hospital acquired infections diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account